Recent Updates
Recently added Catalysts
HYPR Positive Sentiment

MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award

Wednesday, September 16, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Maria Sainz, the President and CEO of Hyperfine, has been awarded the 2026 Ferolyn Powell Leadership Award by MedtechWOMEN. This recognition was announced during the MedtechVISION Annual Conference held in Menlo Park, California. Additionally, Beverly Tang, CEO of Starlight Cardiovascular, received the inaugural Rising Star Award.

Market Sentiment Analysis

POSITIVE FACTORS

  • Maria Sainz recognized for leadership excellence.
  • Award highlights contributions to the medtech industry.
  • Recognition at a prestigious annual conference.

Full Press Release Details

MENLO PARK, Calif.--(BUSINESS WIRE)--MedtechWOMEN today announced that Maria Sainz, President and CEO of Hyperfine, Inc., has been named the recipient of its 2026 Ferolyn Powell Leadership Award, and that Beverly Tang, co-founder and CEO of Starlight Cardiovascular, has received MedtechWOMEN’s first-ever Rising Star Award. Both leaders were recognized at the annual MedtechVISION Annual Conference at the Rosewood Sand Hill in Menlo Park, Calif. Since 2016, the Ferolyn Powell Leadership Award has

Frequently Asked Questions

Who is the recipient of the 2026 Ferolyn Powell Award?

Maria Sainz, President and CEO of Hyperfine, received the award.

What event was the award announced at?

The award was announced at the MedtechVISION Annual Conference.

Who received the Rising Star Award?

Beverly Tang, co-founder and CEO of Starlight Cardiovascular, received it.

Where was the MedtechVISION Annual Conference held?

It was held at the Rosewood Sand Hill in Menlo Park, California.

ShareAdd on Google
Tags: HYPR Viatris Investor Conferences Healthcare Hyperfine Maria Sainz MedtechWOMEN leadership award Beverly Tang
Last updated: Sep 16, 2026

Biotech snapshot

Cash runway
$43M liquidity · $2M/mo burn
~17 mo
Low dilution risk